1. Home
  2. MLYS vs SFIX Comparison

MLYS vs SFIX Comparison

Compare MLYS & SFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • SFIX
  • Stock Information
  • Founded
  • MLYS 2019
  • SFIX 2011
  • Country
  • MLYS United States
  • SFIX United States
  • Employees
  • MLYS N/A
  • SFIX N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • SFIX Catalog/Specialty Distribution
  • Sector
  • MLYS Health Care
  • SFIX Consumer Discretionary
  • Exchange
  • MLYS Nasdaq
  • SFIX Nasdaq
  • Market Cap
  • MLYS 634.6M
  • SFIX 589.8M
  • IPO Year
  • MLYS 2023
  • SFIX 2017
  • Fundamental
  • Price
  • MLYS $9.24
  • SFIX $5.05
  • Analyst Decision
  • MLYS Strong Buy
  • SFIX Hold
  • Analyst Count
  • MLYS 2
  • SFIX 9
  • Target Price
  • MLYS $30.00
  • SFIX $3.96
  • AVG Volume (30 Days)
  • MLYS 266.6K
  • SFIX 3.4M
  • Earning Date
  • MLYS 11-11-2024
  • SFIX 03-03-2025
  • Dividend Yield
  • MLYS N/A
  • SFIX N/A
  • EPS Growth
  • MLYS N/A
  • SFIX N/A
  • EPS
  • MLYS N/A
  • SFIX N/A
  • Revenue
  • MLYS N/A
  • SFIX $1,291,501,000.00
  • Revenue This Year
  • MLYS N/A
  • SFIX N/A
  • Revenue Next Year
  • MLYS N/A
  • SFIX $0.25
  • P/E Ratio
  • MLYS N/A
  • SFIX N/A
  • Revenue Growth
  • MLYS N/A
  • SFIX N/A
  • 52 Week Low
  • MLYS $8.28
  • SFIX $2.06
  • 52 Week High
  • MLYS $16.91
  • SFIX $6.99
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 32.12
  • SFIX 58.49
  • Support Level
  • MLYS $8.60
  • SFIX $4.38
  • Resistance Level
  • MLYS $9.97
  • SFIX $5.36
  • Average True Range (ATR)
  • MLYS 0.88
  • SFIX 0.35
  • MACD
  • MLYS -0.31
  • SFIX 0.07
  • Stochastic Oscillator
  • MLYS 13.25
  • SFIX 79.87

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About SFIX Stitch Fix Inc.

Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.

Share on Social Networks: